Needle-free Hypodermic Syringe Industry Research Report 2025

Summary

According to APO Research, the global Needle-free Hypodermic Syringe market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Needle-free Hypodermic Syringe is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Needle-free Hypodermic Syringe is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Needle-free Hypodermic Syringe is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Needle-free Hypodermic Syringe include Zoetis, Aptar Pharma, Veloxis Pharmaceuticals, SHL Medical, Portal Instruments, PharmaJet, PenJet, Oval Medical Technologies and Lifecare AS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Needle-free Hypodermic Syringe, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-free Hypodermic Syringe.

The report will help the Needle-free Hypodermic Syringe manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Needle-free Hypodermic Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Needle-free Hypodermic Syringe market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Needle-free Hypodermic Syringe Segment by Company

Zoetis
Aptar Pharma
Veloxis Pharmaceuticals
SHL Medical
Portal Instruments
PharmaJet
PenJet
Oval Medical Technologies
Lifecare AS
Enable Injections
Crossject
Antares Pharma
Needle-free Hypodermic Syringe Segment by Type

Electric Needle-Free Injector
Hydraulic Needle-Free Injector
Needle-free Hypodermic Syringe Segment by Application

Hospital
Specialist Clinic
Others
Needle-free Hypodermic Syringe Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Hypodermic Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Needle-free Hypodermic Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Hypodermic Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Needle-free Hypodermic Syringe manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Needle-free Hypodermic Syringe by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Needle-free Hypodermic Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Needle-free Hypodermic Syringe Market Size (2020-2031)
2.2.2 Global Needle-free Hypodermic Syringe Sales (2020-2031)
2.2.3 Global Needle-free Hypodermic Syringe Market Average Price (2020-2031)
2.3 Needle-free Hypodermic Syringe by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Electric Needle-Free Injector
2.3.3 Hydraulic Needle-Free Injector
2.4 Needle-free Hypodermic Syringe by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Specialist Clinic
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Needle-free Hypodermic Syringe Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Needle-free Hypodermic Syringe Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Needle-free Hypodermic Syringe Revenue of Manufacturers (2020-2025)
3.4 Global Needle-free Hypodermic Syringe Average Price by Manufacturers (2020-2025)
3.5 Global Needle-free Hypodermic Syringe Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Needle-free Hypodermic Syringe, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Needle-free Hypodermic Syringe, Product Type & Application
3.8 Global Manufacturers of Needle-free Hypodermic Syringe, Established Date
3.9 Global Needle-free Hypodermic Syringe Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Zoetis Needle-free Hypodermic Syringe Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Aptar Pharma
4.2.1 Aptar Pharma Company Information
4.2.2 Aptar Pharma Business Overview
4.2.3 Aptar Pharma Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio
4.2.5 Aptar Pharma Recent Developments
4.3 Veloxis Pharmaceuticals
4.3.1 Veloxis Pharmaceuticals Company Information
4.3.2 Veloxis Pharmaceuticals Business Overview
4.3.3 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio
4.3.5 Veloxis Pharmaceuticals Recent Developments
4.4 SHL Medical
4.4.1 SHL Medical Company Information
4.4.2 SHL Medical Business Overview
4.4.3 SHL Medical Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.4.4 SHL Medical Needle-free Hypodermic Syringe Product Portfolio
4.4.5 SHL Medical Recent Developments
4.5 Portal Instruments
4.5.1 Portal Instruments Company Information
4.5.2 Portal Instruments Business Overview
4.5.3 Portal Instruments Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Portal Instruments Needle-free Hypodermic Syringe Product Portfolio
4.5.5 Portal Instruments Recent Developments
4.6 PharmaJet
4.6.1 PharmaJet Company Information
4.6.2 PharmaJet Business Overview
4.6.3 PharmaJet Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.6.4 PharmaJet Needle-free Hypodermic Syringe Product Portfolio
4.6.5 PharmaJet Recent Developments
4.7 PenJet
4.7.1 PenJet Company Information
4.7.2 PenJet Business Overview
4.7.3 PenJet Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.7.4 PenJet Needle-free Hypodermic Syringe Product Portfolio
4.7.5 PenJet Recent Developments
4.8 Oval Medical Technologies
4.8.1 Oval Medical Technologies Company Information
4.8.2 Oval Medical Technologies Business Overview
4.8.3 Oval Medical Technologies Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio
4.8.5 Oval Medical Technologies Recent Developments
4.9 Lifecare AS
4.9.1 Lifecare AS Company Information
4.9.2 Lifecare AS Business Overview
4.9.3 Lifecare AS Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Lifecare AS Needle-free Hypodermic Syringe Product Portfolio
4.9.5 Lifecare AS Recent Developments
4.10 Enable Injections
4.10.1 Enable Injections Company Information
4.10.2 Enable Injections Business Overview
4.10.3 Enable Injections Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Enable Injections Needle-free Hypodermic Syringe Product Portfolio
4.10.5 Enable Injections Recent Developments
4.11 Crossject
4.11.1 Crossject Company Information
4.11.2 Crossject Business Overview
4.11.3 Crossject Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Crossject Needle-free Hypodermic Syringe Product Portfolio
4.11.5 Crossject Recent Developments
4.12 Antares Pharma
4.12.1 Antares Pharma Company Information
4.12.2 Antares Pharma Business Overview
4.12.3 Antares Pharma Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Antares Pharma Needle-free Hypodermic Syringe Product Portfolio
4.12.5 Antares Pharma Recent Developments
5 Global Needle-free Hypodermic Syringe Market Scenario by Region
5.1 Global Needle-free Hypodermic Syringe Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Needle-free Hypodermic Syringe Sales by Region: 2020-2031
5.2.1 Global Needle-free Hypodermic Syringe Sales by Region: 2020-2025
5.2.2 Global Needle-free Hypodermic Syringe Sales by Region: 2026-2031
5.3 Global Needle-free Hypodermic Syringe Revenue by Region: 2020-2031
5.3.1 Global Needle-free Hypodermic Syringe Revenue by Region: 2020-2025
5.3.2 Global Needle-free Hypodermic Syringe Revenue by Region: 2026-2031
5.4 North America Needle-free Hypodermic Syringe Market Facts & Figures by Country
5.4.1 North America Needle-free Hypodermic Syringe Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Needle-free Hypodermic Syringe Sales by Country (2020-2031)
5.4.3 North America Needle-free Hypodermic Syringe Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Needle-free Hypodermic Syringe Market Facts & Figures by Country
5.5.1 Europe Needle-free Hypodermic Syringe Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Needle-free Hypodermic Syringe Sales by Country (2020-2031)
5.5.3 Europe Needle-free Hypodermic Syringe Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Needle-free Hypodermic Syringe Market Facts & Figures by Country
5.6.1 Asia Pacific Needle-free Hypodermic Syringe Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2020-2031)
5.6.3 Asia Pacific Needle-free Hypodermic Syringe Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Needle-free Hypodermic Syringe Market Facts & Figures by Country
5.7.1 South America Needle-free Hypodermic Syringe Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Needle-free Hypodermic Syringe Sales by Country (2020-2031)
5.7.3 South America Needle-free Hypodermic Syringe Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Needle-free Hypodermic Syringe Market Facts & Figures by Country
5.8.1 Middle East and Africa Needle-free Hypodermic Syringe Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2020-2031)
5.8.3 Middle East and Africa Needle-free Hypodermic Syringe Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Needle-free Hypodermic Syringe Sales by Type (2020-2031)
6.1.1 Global Needle-free Hypodermic Syringe Sales by Type (2020-2031) & (K Units)
6.1.2 Global Needle-free Hypodermic Syringe Sales Market Share by Type (2020-2031)
6.2 Global Needle-free Hypodermic Syringe Revenue by Type (2020-2031)
6.2.1 Global Needle-free Hypodermic Syringe Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2020-2031)
6.3 Global Needle-free Hypodermic Syringe Price by Type (2020-2031)
7 Segment by Application
7.1 Global Needle-free Hypodermic Syringe Sales by Application (2020-2031)
7.1.1 Global Needle-free Hypodermic Syringe Sales by Application (2020-2031) & (K Units)
7.1.2 Global Needle-free Hypodermic Syringe Sales Market Share by Application (2020-2031)
7.2 Global Needle-free Hypodermic Syringe Revenue by Application (2020-2031)
7.2.1 Global Needle-free Hypodermic Syringe Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2020-2031)
7.3 Global Needle-free Hypodermic Syringe Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Needle-free Hypodermic Syringe Value Chain Analysis
8.1.1 Needle-free Hypodermic Syringe Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Needle-free Hypodermic Syringe Production Mode & Process
8.2 Needle-free Hypodermic Syringe Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Needle-free Hypodermic Syringe Distributors
8.2.3 Needle-free Hypodermic Syringe Customers
9 Global Needle-free Hypodermic Syringe Analyzing Market Dynamics
9.1 Needle-free Hypodermic Syringe Industry Trends
9.2 Needle-free Hypodermic Syringe Industry Drivers
9.3 Needle-free Hypodermic Syringe Industry Opportunities and Challenges
9.4 Needle-free Hypodermic Syringe Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Needle-free Hypodermic Syringe Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Needle-free Hypodermic Syringe Sales (K Units) of Manufacturers (2020-2025)
Table 7. Global Needle-free Hypodermic Syringe Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Needle-free Hypodermic Syringe Revenue of Manufacturers (2020-2025)
Table 9. Global Needle-free Hypodermic Syringe Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Needle-free Hypodermic Syringe Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Needle-free Hypodermic Syringe Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Needle-free Hypodermic Syringe, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Needle-free Hypodermic Syringe, Product Type & Application
Table 14. Global Needle-free Hypodermic Syringe Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Needle-free Hypodermic Syringe by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Zoetis Company Information
Table 19. Zoetis Business Overview
Table 20. Zoetis Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. Zoetis Needle-free Hypodermic Syringe Product Portfolio
Table 22. Zoetis Recent Developments
Table 23. Aptar Pharma Company Information
Table 24. Aptar Pharma Business Overview
Table 25. Aptar Pharma Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio
Table 27. Aptar Pharma Recent Developments
Table 28. Veloxis Pharmaceuticals Company Information
Table 29. Veloxis Pharmaceuticals Business Overview
Table 30. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio
Table 32. Veloxis Pharmaceuticals Recent Developments
Table 33. SHL Medical Company Information
Table 34. SHL Medical Business Overview
Table 35. SHL Medical Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. SHL Medical Needle-free Hypodermic Syringe Product Portfolio
Table 37. SHL Medical Recent Developments
Table 38. Portal Instruments Company Information
Table 39. Portal Instruments Business Overview
Table 40. Portal Instruments Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. Portal Instruments Needle-free Hypodermic Syringe Product Portfolio
Table 42. Portal Instruments Recent Developments
Table 43. PharmaJet Company Information
Table 44. PharmaJet Business Overview
Table 45. PharmaJet Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 46. PharmaJet Needle-free Hypodermic Syringe Product Portfolio
Table 47. PharmaJet Recent Developments
Table 48. PenJet Company Information
Table 49. PenJet Business Overview
Table 50. PenJet Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 51. PenJet Needle-free Hypodermic Syringe Product Portfolio
Table 52. PenJet Recent Developments
Table 53. Oval Medical Technologies Company Information
Table 54. Oval Medical Technologies Business Overview
Table 55. Oval Medical Technologies Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio
Table 57. Oval Medical Technologies Recent Developments
Table 58. Lifecare AS Company Information
Table 59. Lifecare AS Business Overview
Table 60. Lifecare AS Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 61. Lifecare AS Needle-free Hypodermic Syringe Product Portfolio
Table 62. Lifecare AS Recent Developments
Table 63. Enable Injections Company Information
Table 64. Enable Injections Business Overview
Table 65. Enable Injections Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Enable Injections Needle-free Hypodermic Syringe Product Portfolio
Table 67. Enable Injections Recent Developments
Table 68. Crossject Company Information
Table 69. Crossject Business Overview
Table 70. Crossject Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 71. Crossject Needle-free Hypodermic Syringe Product Portfolio
Table 72. Crossject Recent Developments
Table 73. Antares Pharma Company Information
Table 74. Antares Pharma Business Overview
Table 75. Antares Pharma Needle-free Hypodermic Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Antares Pharma Needle-free Hypodermic Syringe Product Portfolio
Table 77. Antares Pharma Recent Developments
Table 78. Global Needle-free Hypodermic Syringe Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 79. Global Needle-free Hypodermic Syringe Sales by Region (2020-2025) & (K Units)
Table 80. Global Needle-free Hypodermic Syringe Sales Market Share by Region (2020-2025)
Table 81. Global Needle-free Hypodermic Syringe Sales by Region (2026-2031) & (K Units)
Table 82. Global Needle-free Hypodermic Syringe Sales Market Share by Region (2026-2031)
Table 83. Global Needle-free Hypodermic Syringe Revenue by Region (2020-2025) & (US$ Million)
Table 84. Global Needle-free Hypodermic Syringe Revenue Market Share by Region (2020-2025)
Table 85. Global Needle-free Hypodermic Syringe Revenue by Region (2026-2031) & (US$ Million)
Table 86. Global Needle-free Hypodermic Syringe Revenue Market Share by Region (2026-2031)
Table 87. North America Needle-free Hypodermic Syringe Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 88. North America Needle-free Hypodermic Syringe Sales by Country (2020-2025) & (K Units)
Table 89. North America Needle-free Hypodermic Syringe Sales by Country (2026-2031) & (K Units)
Table 90. North America Needle-free Hypodermic Syringe Revenue by Country (2020-2025) & (US$ Million)
Table 91. North America Needle-free Hypodermic Syringe Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Needle-free Hypodermic Syringe Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 93. Europe Needle-free Hypodermic Syringe Sales by Country (2020-2025) & (K Units)
Table 94. Europe Needle-free Hypodermic Syringe Sales by Country (2026-2031) & (K Units)
Table 95. Europe Needle-free Hypodermic Syringe Revenue by Country (2020-2025) & (US$ Million)
Table 96. Europe Needle-free Hypodermic Syringe Revenue by Country (2026-2031) & (US$ Million)
Table 97. Asia Pacific Needle-free Hypodermic Syringe Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 98. Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2020-2025) & (K Units)
Table 99. Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2026-2031) & (K Units)
Table 100. Asia Pacific Needle-free Hypodermic Syringe Revenue by Country (2020-2025) & (US$ Million)
Table 101. Asia Pacific Needle-free Hypodermic Syringe Revenue by Country (2026-2031) & (US$ Million)
Table 102. South America Needle-free Hypodermic Syringe Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 103. South America Needle-free Hypodermic Syringe Sales by Country (2020-2025) & (K Units)
Table 104. South America Needle-free Hypodermic Syringe Sales by Country (2026-2031) & (K Units)
Table 105. South America Needle-free Hypodermic Syringe Revenue by Country (2020-2025) & (US$ Million)
Table 106. South America Needle-free Hypodermic Syringe Revenue by Country (2026-2031) & (US$ Million)
Table 107. Middle East and Africa Needle-free Hypodermic Syringe Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 108. Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2020-2025) & (K Units)
Table 109. Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2026-2031) & (K Units)
Table 110. Middle East and Africa Needle-free Hypodermic Syringe Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Needle-free Hypodermic Syringe Revenue by Country (2026-2031) & (US$ Million)
Table 112. Global Needle-free Hypodermic Syringe Sales by Type (2020-2025) & (K Units)
Table 113. Global Needle-free Hypodermic Syringe Sales by Type (2026-2031) & (K Units)
Table 114. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2020-2025)
Table 115. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2026-2031)
Table 116. Global Needle-free Hypodermic Syringe Revenue by Type (2020-2025) & (US$ Million)
Table 117. Global Needle-free Hypodermic Syringe Revenue by Type (2026-2031) & (US$ Million)
Table 118. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2020-2025)
Table 119. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2026-2031)
Table 120. Global Needle-free Hypodermic Syringe Price by Type (2020-2025) & (US$/Unit)
Table 121. Global Needle-free Hypodermic Syringe Price by Type (2026-2031) & (US$/Unit)
Table 122. Global Needle-free Hypodermic Syringe Sales by Application (2020-2025) & (K Units)
Table 123. Global Needle-free Hypodermic Syringe Sales by Application (2026-2031) & (K Units)
Table 124. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2020-2025)
Table 125. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2026-2031)
Table 126. Global Needle-free Hypodermic Syringe Revenue by Application (2020-2025) & (US$ Million)
Table 127. Global Needle-free Hypodermic Syringe Revenue by Application (2026-2031) & (US$ Million)
Table 128. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2020-2025)
Table 129. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2026-2031)
Table 130. Global Needle-free Hypodermic Syringe Price by Application (2020-2025) & (US$/Unit)
Table 131. Global Needle-free Hypodermic Syringe Price by Application (2026-2031) & (US$/Unit)
Table 132. Key Raw Materials
Table 133. Raw Materials Key Suppliers
Table 134. Needle-free Hypodermic Syringe Distributors List
Table 135. Needle-free Hypodermic Syringe Customers List
Table 136. Needle-free Hypodermic Syringe Industry Trends
Table 137. Needle-free Hypodermic Syringe Industry Drivers
Table 138. Needle-free Hypodermic Syringe Industry Restraints
Table 139. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Needle-free Hypodermic Syringe Product Image
Figure 5. Global Needle-free Hypodermic Syringe Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Needle-free Hypodermic Syringe Market Size (2020-2031) & (US$ Million)
Figure 7. Global Needle-free Hypodermic Syringe Sales (2020-2031) & (K Units)
Figure 8. Global Needle-free Hypodermic Syringe Average Price (US$/Unit) & (2020-2031)
Figure 9. Electric Needle-Free Injector Product Image
Figure 10. Hydraulic Needle-Free Injector Product Image
Figure 11. Hospital Product Image
Figure 12. Specialist Clinic Product Image
Figure 13. Others Product Image
Figure 14. Global Needle-free Hypodermic Syringe Revenue Share by Manufacturers in 2024
Figure 15. Global Manufacturers of Needle-free Hypodermic Syringe, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Needle-free Hypodermic Syringe Players Market Share by Revenue in 2024
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 18. Global Needle-free Hypodermic Syringe Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 19. Global Needle-free Hypodermic Syringe Sales by Region in 2024
Figure 20. Global Needle-free Hypodermic Syringe Revenue by Region in 2024
Figure 21. North America Needle-free Hypodermic Syringe Market Size by Country in 2024
Figure 22. North America Needle-free Hypodermic Syringe Sales Market Share by Country (2020-2031)
Figure 23. North America Needle-free Hypodermic Syringe Revenue Market Share by Country (2020-2031)
Figure 24. United States Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Mexico Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Needle-free Hypodermic Syringe Market Size by Country in 2024
Figure 28. Europe Needle-free Hypodermic Syringe Sales Market Share by Country (2020-2031)
Figure 29. Europe Needle-free Hypodermic Syringe Revenue Market Share by Country (2020-2031)
Figure 30. Germany Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Spain Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Netherlands Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Switzerland Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Sweden Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Poland Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Needle-free Hypodermic Syringe Market Size by Country in 2024
Figure 41. Asia Pacific Needle-free Hypodermic Syringe Sales Market Share by Country (2020-2031)
Figure 42. Asia Pacific Needle-free Hypodermic Syringe Revenue Market Share by Country (2020-2031)
Figure 43. China Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Japan Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South Korea Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. India Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Australia Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Taiwan Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. South America Needle-free Hypodermic Syringe Market Size by Country in 2024
Figure 52. South America Needle-free Hypodermic Syringe Sales Market Share by Country (2020-2031)
Figure 53. South America Needle-free Hypodermic Syringe Revenue Market Share by Country (2020-2031)
Figure 54. Brazil Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Chile Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Colombia Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Needle-free Hypodermic Syringe Market Size by Country in 2024
Figure 59. Middle East and Africa Needle-free Hypodermic Syringe Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Needle-free Hypodermic Syringe Revenue Market Share by Country (2020-2031)
Figure 61. Egypt Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. South Africa Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Israel Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Türkiye Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. GCC Countries Needle-free Hypodermic Syringe Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 66. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2020-2031)
Figure 67. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2020-2031)
Figure 68. Global Needle-free Hypodermic Syringe Price (US$/Unit) by Type (2020-2031)
Figure 69. Global Needle-free Hypodermic Syringe Sales Market Share by Application (2020-2031)
Figure 70. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2020-2031)
Figure 71. Global Needle-free Hypodermic Syringe Price (US$/Unit) by Application (2020-2031)
Figure 72. Needle-free Hypodermic Syringe Value Chain
Figure 73. Needle-free Hypodermic Syringe Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Needle-free Hypodermic Syringe Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings